Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring.

Martin WasserbauerŠtěpán HlavaJiri DrabekJan StovicekPetra MinarikovaLenka NedbalovaTomas DrasarZdena ZadorovaJiri DolinaStefan KonecnyVladimír KojeckyJana KozeluhovaPavlina CernikovaDita PichlerovaBarbora KucerovaStepan CoufalRadan Keil

Published in: PloS one (2022)

This prospective observational study proved the effectiveness of the adalimumab biosimilars FKB327 and GP2017 in IBD.

Keyphrases

ulcerative colitis
rheumatoid arthritis
randomized controlled trial
juvenile idiopathic arthritis
systematic review
stem cells
hidradenitis suppurativa
bone marrow
systemic lupus erythematosus
cell therapy
disease activity